Biolase Inc (BIOL)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: DENTAL EQUIPMENT & SUPPLIES

4 CROMWELL IRVINE, CA 92618

Develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. Principle products consist of dental laser systems that allow dentists and other professionals to perform cosmetic and surgical procedures.

Data as of 2020-09-12
Market Cap27.777 Million Shares Outstanding92.191 Million Avg 30-day Volume5.222 Million
P/E Ratio Dividend Yield EPS-0.67
Price/Sales1.046 Price cash flow ratio Price free cash flow ratio-1.8
Book Value0.01 Price to Tangible Book-17.09 Alpha-0.05
Short Interest Ratio % Short Interest to Float R-squared0.124026
BETA1.94388 52-week High/Low1.1574 / 0.211 Stddev0.235842
View SEC Filings from BIOL instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 30 29 3.45% 5 (0.33%) 7 (0.45%) -28.57%
13F shares: 4.056 Million 12.004 Million -66.21% 2.401 Million 10.548 Million -77.23%
% Ownership 8.0563 38.0157 -78.81% 4.7701 33.4035 -85.72%
New Positions: 7 7 0.0% 2
Increased Positions 8 7 14.29% 1 4 -75.0%
Closed Positions 4 4 0.0% 3 1 200.0%
Reduced Positions 3 3 0.0% 1 1 0.0%
Total Calls 0 0
Total Puts 0 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BIOL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIOL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LORD JONATHAN T MD

  • Director
0 2020-08-06 3

BEAVER JOHN R EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2020-08-06 3

LANMAN RICHARD B.

  • Director
0 2020-08-06 2

SATO GARRETT

  • Director
0 2020-08-06 2

ROPER JESS

  • Director
0 2020-08-06 2

NORBE TODD PRESIDENT AND CEO

  • Officer
  • Director
0 2020-08-06 3

WAGNER ELAINE C

  • Director
0 2020-08-06 2

DITOLLA MICHAEL

  • Director
0 2020-08-06 3

FEINBERG LARRY N

ORACLE PARTNERS LP

  • 10% Owner
5,190,227 2020-06-08 1

SCHULER JACK W

759,820 2020-02-11 1

TALEVICH JAMES R

  • Director
20,374 2018-05-11 0

FLYNN HAROLD C JR. PRESIDENT AND CEO

  • Officer
  • Director
228,690 2017-12-05 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
30,866,265 2017-12-04 0

MOLL FREDERIC H

  • Director
251,317 2017-06-30 0

CLARK PAUL N

  • Director
1,629,007 2017-06-30 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

  • 10% Owner
18,320,650 2017-06-30 0

NELSON MARK JOSEPH SVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2017-04-18 0

SCHULER JACK W

JACK W. SCHULER LIVING TRUST

10,338,756 2016-12-29 0

DREYER DAVID C SVP / CHIEF FINANCIAL OFFICER

  • Officer
123,000 2016-07-01 0

JACK W. SCHULER LIVING TRUST

  • 10% Owner
5,885,603 2015-11-23 0

FEINBERG LARRY N

  • 10% Owner
10,529,525 2015-11-11 0

NUGENT JEFFREY M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
92,548 2014-11-03 0

SCHULER FAMILY FOUNDATION

  • 10% Owner
0 2014-11-03 0

ARROW ALEXANDER K. PRESIDENT AND COO

  • Officer
110,387 2014-07-22 0

FURRY FREDERICK D. CHIEF FINANCIAL OFFICER

  • Officer
18,020 2014-07-22 0

LOW SAMUEL BERNARD

  • Director
0 2013-12-10 0

ENRIGHT ERIN S.

  • Director
0 2013-06-07 0

NEMOY NORMAN J.

  • Director
0 2013-06-06 0

LICHTWARDT GREGORY

  • Director
0 2013-06-06 0

PIGNATELLI FEDERICO CHAIRMAN AND CEO

  • Officer
  • Director
0 2012-11-08 0

MULDER DAVID M

  • FORMER DIRECTOR AND CEO
No longer subject to file 2010-09-30 0

LAIRD NEIL J

  • FORMER DIRECTOR
No longer subject to file 2010-05-27 0

DARBELOFF GEORGE V

  • Director
0 2010-05-05 0

ANDERTON ROBERT M

  • Director
0 2010-05-05 0

LARGENT JAMES R

  • Director
0 2010-05-05 0

WALLER GREGORY D

  • Director
0 2010-05-05 0

DURRIE DANIEL S

  • Director
58,736 2009-08-25 0

CAPALLO FRED INTERIM CHIEF FINANCIAL OFF.

  • Officer
No longer subject to file 2009-08-25 0

SCOTT BRETT L CHIEF FINANCIAL OFFICER

  • Officer
0 2009-07-14 0

ST PHILIP JAKE CEO

  • Officer
  • Director
40,000 2008-05-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ROPER JESS - Director

2020-08-10 09:46:32 -0400 2020-08-06 A 20,000 a 260,397 direct

SATO GARRETT - Director

2020-08-10 09:47:44 -0400 2020-08-06 A 20,000 a 245,856 direct

LORD JONATHAN T MD - Director

2020-08-10 09:51:05 -0400 2020-08-06 A 20,000 a 443,602 direct

BEAVER JOHN R - Officer EVP & CHIEF FINANCIAL OFFICER

2020-08-10 18:37:30 -0400 2020-08-06 A 200,000 a 250,692 direct

WAGNER ELAINE C - Director

2020-08-10 09:48:58 -0400 2020-08-06 A 20,000 a 245,856 direct

LANMAN RICHARD B. - Director

2020-08-10 09:45:11 -0400 2020-08-06 A 20,000 a 245,856 direct

NORBE TODD - Director - Officer PRESIDENT AND CEO

2020-08-10 18:32:45 -0400 2020-08-06 A 200,000 a 833,333 direct

DITOLLA MICHAEL - Director

2020-08-10 09:49:55 -0400 2020-08-06 A 20,000 a 273,988 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments